ARTICLE | Clinical News
Budesonide inhalation suspension: Began U.S. testing
April 9, 2001 7:00 AM UTC
Sheffield Pharmaceuticals Inc. (SHM), St Louis, Mo. Product: Budesonide inhalation suspension Business: Autoimmune/Inflammation Therapeutic category: Steroid Target: Immune cells Description: Inhaled ...